NAD+ (BUFFERED) 500mg
NAD+ 500mg CB-8502026-P
Independent laboratory testing confirms the purity and composition of this batch.
Sample Summary
| CAS | 53-84-9 |
| Batch / Lot | CB-8502026-P |
| Product | White Lyophilized Powder |
| Volume | 481mg |
| Accession # | CB-8502026-P |
| Test Date | 2026-06-05 |
| Identity | C₂₁H₂₇N₇O₁₄P₂ |
Purity Analysis
| Purity | 99.62% |
| Identity | NAD+ |
| Test Method | Qualitative and Quantitative chemical analysis by Ultra High Performance Liquid Chromatography with Mass Spectrometry |
Certificate PDF
Test History
FAQ
This certificate confirms the identity, purity, and endotoxin levels of this specific batch. All testing is performed by an independent, ISO-accredited third-party laboratory.
Endotoxin testing measures bacterial lipopolysaccharides that can cause inflammatory responses. Our standard is less than 5 EU/mg, consistent with pharmaceutical-grade research peptides.
Purity is measured using High-Performance Liquid Chromatography (HPLC), which separates and quantifies each component of the peptide sample.
Yes. The full laboratory report is available as a PDF download above. If you need additional documentation, contact our support team.